当前位置:循环首页>正文

[ESH2012]早期降压治疗能预防高血压吗?

作者:  T.Kahan   日期:2012/6/29 11:01:16

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

High blood pressure is globally the most important risk factor for premature death, both in the developing countries and in the developed parts of the world. Furthermore, the number of hypertensive subjects will increase, due an increasing global population and due to an increasing global rate of hypertension.

  Thomas Kahan    瑞典卡罗琳斯卡医学院
  High blood pressure is globally the most important risk factor for premature death, both in the developing countries and in the developed parts of the world. Furthermore, the number of hypertensive subjects will increase, due an increasing global population and due to an increasing global rate of hypertension. Thus, it is estimated that there will be some 1.56 billion hypertensive subjects by the year 2025 globally.
  The future risk for cardiovascular complications and death associated with hypertension (usually a blood pressure 140/90  mm  Hg or more) is well established. However, a blood pressure level of 130~139/80~89  mm  Hg, termed high-normal blood pressure or prehypertension or borderline hypertension, has also been demonstrated to confer an approximately two fold increased risk for future cardiovascular events. Of note, the blood pressure measured already during adolescence predicts future mortality. Furthermore, blood pressure tracking is strong, and childhood blood pressure is associated with blood pressure in adult life, suggesting that early intervention may be of importance.
  Given this information, can early antihypertensive treatment actually prevent hypertension? Animal experiments have shown that early brief treatment with drugs that inhibit the renin-angiotensin-aldosterone system can prevent the development of high blood pressure later in life. In man, antihypertensive drugs given as secondary prevention following a cardiovascular event to patients with a high-normal blood pressure can reduce future cardiovascular mortality and all cause mortality.However, few studies have examined if antihypertensive drug treatment can prevent hypertension. There is some evidence to suggest that drug therapy given to subjects with a blood pressure of 130-140/80-90 mm Hg could delay the onset of hypertension, but no study to show that a brief period of drug treatment has any major effect in the prevention of  later development of hypertension.
  In man, drugs blocking the renin-angiotensin-aldosterone system may delay incident hypertension. Properly designed studies to determine the efficacy of drug therapy in high-normal blood pressure on clinical outcome are needed. Lifestyle intervention is recommended as it improves cardiovascular risk profile, but drugs are more convenient and more likely to be adhered to than lifestyle modifications. Safety issues and cost effectiveness of long-term treatment in high-normal blood pressure need to be addressed. Until further evidence is revealed, assessment of global absolute risk should guide the decision to use antihypertensive drugs in subjects with high-normal blood pressure levels.

版面编辑:赵书芳  责任编辑:聂会珍



降压治疗高血压

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530